Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: a non-randomised phase 2 clinical trial
Titel:
Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: a non-randomised phase 2 clinical trial
Auteur:
Grignani, Giovanni Palmerini, Emanuela Ferraresi, Virginia D'Ambrosio, Lorenzo Bertulli, Rossella Asaftei, Sebastian Dorin Tamburini, Angela Pignochino, Ymera Sangiolo, Dario Marchesi, Emanuela Capozzi, Federica Biagini, Roberto Gambarotti, Marco Fagioli, Franca Casali, Paolo Giovanni Picci, Piero Ferrari, Stefano Aglietta, Massimo